International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 806

PDF Downloaded: 512


Get Permission Kumar B G, Goud, Vishwanath, and Krishna C S: Correlation of serum hyaluronic acid with diabetic indices in type 2 diabetes mellitus patients with diabetic nephropathy


Introduction

Diabetes is the most widely prevalent chronic metabolic disease. The macrovascular and microvascular diabetic complications like retinopathy, nephropathy, and neuropathy, occurring as a result of enhanced atherogenesis in diabetes are linked with the increased medical and socioeconomic burden.1,2

HA, a member of glycosaminoglycans (GAGs) is a linear polymer, which comprises the major fraction of carbohydrates in ECM (Extracellular Matrix). Generally, HA is present in low amounts in blood vessels but raises intensely in vascular diseases.3,4,5

Hyaluronic acid (HA) is a sulfate-free glycosaminoglycan consisting of repeating disaccharide units, D-glucuronic acid, and N-acetyl-D-glucosamine. It is produced by arterial wall cells (fibroblasts, endothelial cells) and participates in the regulation of cellular processes such as adhesion, migration, and proliferation.6 The interaction of HA with receptors of cell membrane adds to morphogenesis, tissue remodeling, and inflammation.7

The length of HA influences the biological function. High molecular weight HA (106 Da) inhibits angiogenesis, while degradation products of HA of 3–25 disaccharide units stimulate angiogenesis. Along with other glycosaminoglycans (GAGs), HA has a critical role in the interaction of vascular tissue and blood components. GAGs reduces the interaction between endothelial cells and leukocytes.8

The vascular endothelium is coated by a so-called glycocalyx, one of the factors known to maintain vascular homeostasis.9 Hyaluronan glycosaminoglycans, are the major constituents of the glycocalyx which are crucial for preserving the properties of an endothelial barrier for plasma macromolecule.10

The extracellular network (ECM) gives imperative help to vascular tissue which goes about as a stage for protecting the arrangement of vascular cells into blood vessels, for maintaining the equilibrium, for cell multiplication, migration, and survival. The striking changes in this extracellular grid have been connected to the advancement of atherosclerosis.11,12,13 Angiogenic Hyaluronan oligomers exhibit competition with non-angiogenic native long-chain HA in binding to HA receptor CD44 which are present on endothelial cells.14 Activation of CD44 is mitogenic and triggers MMP-2(Matrix Metallo -Proteinases) and MMP-9 production which in turn activates transforming growth factor-beta (TGF-β) and cell invasion through ECM to facilitate vascular sprouting and outgrowth.15 Increased HA fragments in response to hyperglycemia promote activation, migration, and proliferation of cells16,17,18,19,20,21,22 via interactions with its receptors,23 including Receptor for Hyaluronan Mediated Motility(RHAMM),24 CD44,25 and Toll-like receptors 2 and/or 4.26

The current study aims to determine the association of serum Hyaluronic Acid levels in Type 2 diabetes mellitus with diabetic nephropathy and its correlation with diabetic indices and renal function test parameters.

Materials and Methods

The study included 60 male subjects with 30 cases and 30 controls. The study was led at Victoria Hospital, joined to Bangalore Medical College and Research Institute, Bangalore. Clinically diagnosed Type 2 DM male patients with diabetic nephropathy between age bunch 50-60 years were incorporated into the study.30 age and sex coordinated non-diabetic healthy people were taken as controls. Patients with alcoholism, patients with liver disease and patients with serious cardiovascular issues were excluded from the study.

Method of analysis

Ethical committee clearance was obtained from the institution for the study. After obtaining written informed consent from the cases and controls, about 5 ml of fasting venous blood sample was obtained by venepuncture under aseptic conditions and divided into 2 parts, first part of blood was taken in a sterile EDTA tube and was used for measuring-g HbA1C and second in a plain tube, centrifuged and separated serum was used for measuring HA, fasting blood glucose. The postprandial blood sample was collected at 2 hours in a plain tube for PPBS, HbA1c, FBS and PPBS were measured in automated analyzer BECKMAN COULTER AU480. Serum Hyaluronic acid was measured by ELISA. 24 hours urine sample was collected and analyzed for urinary microalbumin by the immunoturbidimetric method in automated analyser BECKMAN COULTER AU480 The results were tabulated. Results are presented on Mean± SD. The Statistical analysis of data was done by using software namely SPSS 20.0. The results of cases and controls were compared by student ‘t’ test. A ‘ p ’ value of <0.05 was considered significant. Pearson’s Correlation analysis was used for correlation tests. A ‘ p ’ value of <0.0001 was considered highly significant.

Results

A comparative study with 30 male Type 2 diabetic nephropathy cases and 30 male controls was undertaken and FBS, PPBS, HbA1C, serum urea, serum creatinine, HA and urinary microalbumin levels were studied. The age distribution pattern of controls and diabetic nephropathy cases under study which ranges from 50-60 years with a mean age of 54.67±2.30 in controls and in cases 58.41 ±2.1 (p=0.50).

The study showed significantly higher serum levels of HA (p<0.0001) in diabetic patients with nephropathy (75.17±6.23ng/ml) than in the normal healthy controls (39.8±8.4 ng/ml).

The correlation study revealed a significant positive correlation between HA and FBS, PPBS and HbA1c (r=0.8892; r=0.8744; r=0.8544) in diabetic nephropathy cases, whereas there is a negative correlation between HA and FBS, PPBS and HbA1c (r = - 0.0 134 ; r =-0.1903 ; r =-0.2786) in control group. Correlation study also revealed a positive correlation between HA and blood urea (r = 0.8545) in cases where as control group shows negative correlation between serum SA and blood urea (r=-0.155). There is a positive correlation between serum SA and serum creatinine in cases (r = 0.9032) and a negative correlation in controls (r = -0.324). There was a positive correlation between HA and urinary microalbumin (r = 0.3121) in cases and negative correlation in controls (r = -0.3219). (Table 2).

Table 1
Lab Variables Controls Cases p value
Age in years 5 4.67 ±2.30 58.41 ± 2.1 0.50
Gender-Males 30 30 1
Serum HA (ng/ml) 38.2±4.86 75.17±6.23 <0.0001
FBS (mg/dl) 86.77±4.66 160.2±27.5 <0.0001
PPBS(mg/dl) 123.93±5.76 250.14±48.12 <0.0001
HbA1C(%) 4.81±0.26 7.3±0.87 <0.0001
Serum Urea 25.6±2.63 69.31±4.64 <0.0001
Serum Creatinine 1.01±0.21 2.94±0.40 <0.0001
Urinary Microalbumin 9.66± 1.05 149.79±30.83 <0.0001

Comparison of means of serum HA, FBS, PPBS and HBA1C in two groups studied

Table 2
S. no HA vs Other Parameters Cases Controls
r value p value r value p value
1. HA (ng/ml) Vs FBS (mg/dl) 0.8892 <0.0001 -0.0134 0.9190
2. HA (ng/ml) Vs PPBS (mg/dl) 0.8744 <0.0001 -0.1903 0.1452
3. HA (ng/ml) Vs HBA1C (%) 0.8544 <0.0001 -0.2786 0.0311
4. HA (ng/ml) Vs urea (mg/dl) 0.8545 <0.0001 -0.0169 0.8980
5. HA (ng/ml) Vs creatinine (mg/dl) 0.9032 <0.0001 -0.3240 0.0115
6. HA (ng/ml) Vs Urinary Microalbumin (mg/g Cr) 0.3121 <0.0100* -0.3219 0.0121

Correlation of Serum HA with FBS, PPBS, HBA1C, Urea, Creatinine and Urinary Microalbuminin in controls and cases studied

Discussion

This study was conducted to determine the association of serum Hyaluronic Acid levels in Type 2 diabetes mellitus with diabetic nephropathy and its correlation with diabetic indices and renal function test parameters. Our study showed a significantly high levels of serum Hyaluronic acid and also significant positive correlation with short term diabetic indices FBS and PPBS and with long term diabetic index HbA1c in diagnosed cases of type 2 DM with nephropathy as compared to non-diabetic healthy controls suggesting elevated hyaluronic acid levels in response to poor glucose control in accordance with the study conducted by Shinichiro et al27 which showed a significant high levels of serum HA in type 2 diabetes without complications and much higher levels in diabetes with complications.

The current study also demonstrates a highly significant positive correlation between serum HA and renal function test parameters serum urea, creatinine, and urine microalbumin This is supported by Sano et al study,28 which showed proteinuria increases the accumulation of HA. Another study by Akin et al29 showed that serum HA levels increased as the amount of proteinuria in the 24-hour urine increases. An increased HA production by proximal tubular cells, renal fibroblasts, mesangial cells, glomeruli in diabetic kidneys has been reported. Renal HA expression is increased in some chronic disease states, such as diabetes and nephrolithiasis, which in turn have the potential to lead to chronic renal insufficiency.30

The study conducted by Hansell et al31 showed that though HA is not a major component of the normal renal corticointerstitium, it is profoundly expressed around proximal tubular cells (PTC) in diverse renal diseases.32,33,34 The study conducted by Jones et al35 has demonstrated that on exposure to high concentrations of glucose in vitro, HA synthesis by proximal tubular cells was initiated.

The study carried out by Mahadevan et al36 postulated the role of HA in the pathogenesis of diabetic nephropathy and its involvement in the initiation of glomerular hypercellularity in the streptozotocin model of diabetes following the publication of the observations that increased hyaluronan production. Thus, in conditions of hyperglycemia, elevated HA accumulates in blood vessels and possibly contributes to the complications of diabetes at micro and microvascular levels.

Conclusion

From the findings of the present study, it can be concluded that Type 2 diabetes mellitus with nephropathy was associated with a significant increase in serum HA levels as compared to controls. Serum HA levels showed a significant positive correlation with FBS, PPBS and HbA1c and significant positive correlation with renal function parameters in this study reflects its role in diabetic nephropathy. Therefore, it is possible that serum HA levels may indicate general impairment of blood vessels caused by hyperglycemia due to inappropriate blood glucose control in diabetes. This elevated HA levels may further contribute to vascular damage resulting in vascular complications of Type 2 Diabetes and hence can be used as a predictive marker of diabetes-related vascular complications in Type 2 Diabetics without complications.

Source of funding

None.

Conflict of interest

None.

References

1 

Biochemistry and molecular cell biology of diabetic complicationsNature20014146865813813

2 

J Nigro N Osman A M Dart P J Little Insulin resistance and atherosclerosisEndocrine reviews2006273242259

3 

D Jiang J Liang P W Noble Hyaluronan as an immune regulator in human diseasesPhysiol Rev2011911221264

4 

T C Laurent U B Laurent J R Fraser The structure and function of hyaluronan: an overviewImmunol Cell Biol199674217

5 

P L Bollyky B A Falk R P Wu J H Buckner T N Wight G T Nepom Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+ CD25+ regulatory T cellsJ Leukocyte Biol2009863567572

6 

M G Neuman L B Cohen R M Nanau Hyaluronic acid as a non-invasive biomarker of liver fibrosisClin Biochem2016493302315

7 

H Levesque N Girard C Maingonnat A Delpech C Chauzy J Tayot H Courtois B Delpech Localization and solubilization of hyaluronan and of the hyaluronan-binding protein hyaluronectin in human normal and arteriosclerotic arterial wallsAtheroscler199410515162

8 

R Deed P Rooney P Kumar J D Norton J Smith A J Freemont Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronanInt J Cancer1997712251256

9 

M Nieuwdorp M C Meuwese H Vink J B Hoekstra J J Kastelein E S Stroes The endothelial glycocalyx: a potential barrier between health and vascular diseaseCurr Opin Lipidol2005165507511

10 

C B Henry B R Duling Permeation of the luminal capillary glycocalyx is determined by hyaluronanAm J Physiol-Heart Circ Physiol19992772508514

11 

G E Davis D R Senger Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilizationCirc Res2005971110931107

12 

R Ross Atherosclerosis-an inflammatory diseaseNew Engl J Med19993402115126

13 

D Vigetti P Moretto M Viola A Genasetti M Rizzi E Karousou Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro agingThe FASEB J200620811181130

14 

E L Pardue S Ibrahim A Ramamurthi Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineeringOrganogenesis200844203214

15 

Q Yu I Stamenkovic Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF- and promotes tumor invasion and angiogenesisGenes Dev2000142163176

16 

D Jiang J Liang P W Noble Hyaluronan as an immune regulator in human diseasesPhysiol Rev2011911221264

17 

T C Laurent U B Laurent J R Fraser The structure and function of hyaluronan: an overviewImmunol Cell Biol199674217

18 

P L Bollyky B A Falk R P Wu J H Buckner T N Wight G T Nepom Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+ CD25+ regulatory T cellsJ Leukoc Biol2009863567572

19 

P L Bollyky R P Wu B A Falk J D Lord S A Long A Preisinger ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursorsProc Natl Acad Sci201110879387943

20 

C De La Motte J Nigro A Vasanji H Rho S Kessler S Bandyopadhyay Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokinesThe Am J Pathol2009174622542264

21 

C M Mckee M B Penno M Cowman M D Burdick R M Strieter C Bao Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44The J Clin Invest1996981024032413

22 

K A Scheibner M A Lutz S Boodoo M J Fenton J D Powell M R Horton Hyaluronan fragments act as an endogenous danger signal by engaging TLR2The J Immunol2006177212721281

23 

D G Jackson Hyaluronan in the lymphatics: the key role of the hyaluronan receptor LYVE-1 in leucocyte traffickingMatrix Biol2018

24 

R C Savani C Wang B Yang S Zhang M G Kinsella T N Wight Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMMThe J Clin Investig199595311581168

25 

P Johnson B Ruffell CD44 and its role in inflammation and inflammatory diseasesInflamm Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy)200983208220

26 

C Termeer F Benedix J Sleeman C Fieber U Voith T Ahrens Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4J Exp Med2002195199111

27 

S Mine Y Okada C Kawahara T Tabata Y Tanaka Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitusEndocr J2006609110032609110032

28 

N Sano K Kitazawa T Sugisaki Localization and roles of CD44, hyaluronic acid and osteopontin in IgA nephropathyNephron200189416421

29 

D Akin S Ozmen M E Yilmaz Hyaluronic acid as a new biomarker to differentiate acute kidney injury from chronic kidney diseaseIranian J Kidney Dis2017116409

30 

S Stridh F Palm P Hansell Renal interstitial hyaluronan: functional aspects during normal and pathological conditionsIntegr Comp Physiol2012183021112351249Am J Physiol-Regul

31 

P Hansell V Gransson C Odlind B Gerdin R Hllgren Hyaluronan content in the kidney in different states of body hydrationKidney Int200058520612068

32 

A F Wells E R Larsson A N Tengblad B E Fellstrm G U Tufveson L A Klareskog The localization of hyaluronan in normal and rejected human kidneysTransplant1990502240243

33 

V Sibalic X Fan J Loffing R P Wrthrich Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritisNephrol Dial. Transplant19971213441353

34 

A J P Lewington B J Padanilam D R Martin M R Hammeramn Expression of CD44 in kidney after acute ischemic injury in ratsAm J Physiol2000278247254

35 

S G Jones S Jones A O Phillips Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathyKidney Int20015917391749

36 

P Mahadevan R G Larkins J R Fraser A J Fosang M E Dunlop Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycanDiabetologia1995383298305



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

526-529


Authors Details

Prashanth Kumar B G, Soumya Goud, H L Vishwanath, Muralidhara Krishna C S


Article Metrics


View Article As

 


Downlaod Files